Literature DB >> 21650153

Biosynthetic origin of the 3-amino-2,5,7,8-tetrahydroxy-10-methylundecanoic acid moiety and absolute configuration of pahayokolides A and B.

Li Liu1, Daniel W Bearden, Kathleen S Rein.   

Abstract

class="Chemical">Pahayokolides A n class="Chemical">and B are cyclic undecapeptides that were isolated from the cyanobacterium Lyngbya sp. They contain the unusual α-hydroxy-β-amino acid 3-amino-2,5,7,8-tetrahydroxy-10-methylundecanoic acid (Athmu). The absolute configurations of the amino acids of the pahayokolides, except for the four oxygen-bearing stereocenters of Athmu, have been determined by Marphy's method. Incorporation of labeled leucine and acetate precursors into the pahayokolides has established that Athmu is derived from a leucine or α-keto isocaproic acid starter unit, which is further extended with three acetate units.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21650153      PMCID: PMC3163906          DOI: 10.1021/np200362q

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  8 in total

1.  7-Epicylindrospermopsin, a toxic minor metabolite of the cyanobacterium Aphanizomenon ovalisporum from lake Kinneret, Israel.

Authors:  R Banker; B Teltsch; A Sukenik; S Carmeli
Journal:  J Nat Prod       Date:  2000-03       Impact factor: 4.050

2.  Synergistic allelochemicals from a freshwater cyanobacterium.

Authors:  Pedro N Leão; Alban R Pereira; Wei-Ting Liu; Julio Ng; Pavel A Pevzner; Pieter C Dorrestein; Gabriele M König; Vitor M Vasconcelos; William H Gerwick
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

3.  Solution structure of nodularin. An inhibitor of serine/threonine-specific protein phosphatases.

Authors:  A Annila; J Lehtimäki; K Mattila; J E Eriksson; K Sivonen; T T Rantala; T Drakenberg
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

4.  Pharmacology and toxicology of pahayokolide A, a bioactive metabolite from a freshwater species of Lyngbya isolated from the Florida Everglades.

Authors:  John P Berry; Miroslav Gantar; Robert E Gawley; Minglei Wang; Kathleen S Rein
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2004-12       Impact factor: 3.228

5.  Structures of pahayokolides A and B, cyclic peptides from a Lyngbya sp.

Authors:  Tianying An; Thallapuranam Krishnaswamy Suresh Kumar; Minglei Wang; Li Liu; Jackson O Lay; Rohana Liyanage; John Berry; Miroslav Gantar; Vered Marks; Robert E Gawley; Kathleen S Rein
Journal:  J Nat Prod       Date:  2007-04-14       Impact factor: 4.050

Review 6.  Bioactive natural products from marine cyanobacteria for drug discovery.

Authors:  Lik Tong Tan
Journal:  Phytochemistry       Date:  2007-03-02       Impact factor: 4.072

7.  Structural organization of microcystin biosynthesis in Microcystis aeruginosa PCC7806: an integrated peptide-polyketide synthetase system.

Authors:  D Tillett; E Dittmann; M Erhard; H von Döhren; T Börner; B A Neilan
Journal:  Chem Biol       Date:  2000-10

8.  Lyngbyazothrins A-D, antimicrobial cyclic undecapeptides from the cultured Cyanobacterium lyngbya sp.

Authors:  Elmi N Zainuddin; Rolf Jansen; Manfred Nimtz; Victor Wray; Michael Preisitsch; Michael Lalk; Sabine Mundt
Journal:  J Nat Prod       Date:  2009-08       Impact factor: 4.050

  8 in total
  3 in total

Review 1.  Nonproteinogenic amino acid building blocks for nonribosomal peptide and hybrid polyketide scaffolds.

Authors:  Christopher T Walsh; Robert V O'Brien; Chaitan Khosla
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-31       Impact factor: 15.336

Review 2.  Chemical compounds toxic to invertebrates isolated from marine cyanobacteria of potential relevance to the agricultural industry.

Authors:  Magbubah Essack; Hanin S Alzubaidy; Vladimir B Bajic; John A C Archer
Journal:  Toxins (Basel)       Date:  2014-10-29       Impact factor: 4.546

Review 3.  The Desotamide Family of Antibiotics.

Authors:  Asif Fazal; Michael E Webb; Ryan F Seipke
Journal:  Antibiotics (Basel)       Date:  2020-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.